Raniya Kassem Colten's Email Addresses & Phone Numbers

💼 Past Experience

During her time at Regeneron Pharmaceuticals, Raniya Kassem Coltensupervised the clinical operations of multiple Phase 2 diabetes trials, drew up monitoring and communication plans for multiple programs, devised strategy forENGTHY data collection, streamline data capture processes, initiated and successfully executed vendor communication, instituted successful site training and management plans, and met project guidelines. She also carried out projects such as the restructuring of an at-risk, single-center, IV formulation clinical trial in France with 144 healthy volunteers and the implementation of a communication plan, established documents and tools, restructured procedures, streamlined processes, and facilitated the attainment and sharing of accurate and timely data.Raniya Kassem Colten also had a role in the development and management of international studies for Roche Pharmaceuticals. She oversaw the integration of an old $5 million phase 2, global virology study and oversaw the successful filing of Zelboraf, a compound used for the treatment of BRAFV600E mutation-positive metastatic melanoma.

🎓 Education

Raniya Kassem Colten studied Social Work and Women'sStudies at Albright College. After completing her undergraduate studies, she worked as a social worker in New York City for six years. In 2009 she earned her Master's degree in Social Work from New York University.Since then, she has been working as a social worker in Perth, Australia.Currently, Raniya Kassem Colten is a social worker in Perth, Australia. She is interested in working with children, adolescents and families. Raniya Kassem Colten is experienced in working with a wide variety of populations, and is comfortable working with children in difficult circumstances. She is able to empathize with children and provide them with the support they need.Raniya Kassem Colten is committed to her work, and is always eager to learn more about and help improve the lives of her clients. She is passionate about her work, and is constantly looking for ways to improve her skills and increase her impact.Raniya Kassem Colten has a wealth of experience that she feels will be valuable to her new role as a social worker in Perth, Australia. She is excited to take on her new position, and is committed to providing her clients with the best possible service.

💡 Technical & Interpersonal Skills

COLTENSE Raniya Kassem is currently a Senior Manager at Regeneron Pharmaceuticals, Inc. in Tarrytown, NY. Raniya Kassem Colten has worked in a variety of roles within the pharmaceutical industry for over 7 years. She worked as a Consultant at TB Alliance from 2014 to 2015 in Greater New York City Area. She was then a Senior Manager at Regeneron Pharmaceuticals, Inc. from January 2018 to May 2020 in Nutley, NJ. Raniya Kassem Colten also has a background in Clinical Operations at Daiichi Sankyo, Inc. from January 2018 to May 2020. In her previous roles, she was responsible for operational oversight of Expanded Access Programs for an acquired Oncology product used to treat acute Graft vs Host Disease (aGvHD) in children and adults in preparation for Agency (FDA) filing. She also was accountable for overall operational planning, coordination, and performance management of multiple Phase 2 studies in Diabetes. Raniya Kassem Colten has alsorecognized her leadership from her previous roles at Intercell AG (Formerly IOMAI) from November 2006 to March 2008 and Schering-Plough Research Institute from 2005 to 2006. Raniya Kassem Colten is currently a Senior Manager at Regeneron Pharmaceuticals, Inc. in Tarrytown, NY. Raniya Kassem Colten has worked in a variety of roles within the Pharmaceutical industry for over 7 years. In her previous roles, she was responsible for operational oversight of Expanded Access Programs for an acquired Oncology product used to treat acute Graft vs Host Disease (aGvHD) in children and adults in preparation for Agency (FDA) filing. She also was accountable for overall operational planning, coordination, and performance management of multiple Phase 2 studies in Diabetes. Raniya Kassem Colten has alsorecognized her leadership from her previous roles at Intercell AG (Formerly IOMAI) from November 2006 to March 2008 and Schering-Plough Research Institute from 2005 to 2006.